Total Payments
$13,732
2023 Payments
$164.35
Companies
11
Transactions
34
Medicare Patients
530
Medicare Billing
$49,495
Payment Breakdown by Category
Other$6,677 (48.6%)
Travel$2,912 (21.2%)
Consulting$2,400 (17.5%)
Food & Beverage$1,705 (12.4%)
Education$37.65 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $6,600 | 2 | 48.1% |
| Travel and Lodging | $2,912 | 8 | 21.2% |
| Consulting Fee | $2,400 | 4 | 17.5% |
| Food and Beverage | $1,705 | 18 | 12.4% |
| Debt forgiveness | $76.90 | 1 | 0.6% |
| Education | $37.65 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $9,373 | 12 | $0 (2017) |
| UCB, Inc. | $2,523 | 5 | $0 (2018) |
| Covidien LP | $976.36 | 6 | $0 (2018) |
| INTERCEPT PHARMACEUTICALS, INC. | $199.60 | 2 | $0 (2023) |
| Shire North American Group Inc | $156.88 | 2 | $0 (2017) |
| Allergan Inc. | $150.00 | 1 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $113.18 | 2 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $100.54 | 1 | $0 (2017) |
| DJO, LLC | $76.90 | 1 | $0 (2023) |
| ABBVIE INC. | $59.75 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $164.35 | 4 | DJO, LLC ($76.90) |
| 2018 | $1,050 | 4 | UCB, Inc. ($800.00) |
| 2017 | $12,518 | 26 | Valeant Pharmaceuticals North America LLC ($9,373) |
All Payment Transactions
34 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2023 | DJO, LLC | — | Debt forgiveness | Cash or cash equivalent | $76.90 | General |
| 08/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Gastroenterology | ||||||
| 08/16/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/09/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $59.75 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2018 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | — | Food and Beverage | In-kind items and services | $100.08 | General |
| 05/22/2018 | Covidien LP | Smart Pill (Device) | Food and Beverage | In-kind items and services | $149.48 | General |
| Category: GI Solutions | ||||||
| 02/01/2018 | UCB, Inc. | Cimzia (Drug) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Immunology | ||||||
| 01/10/2018 | UCB, Inc. | Cimzia (Drug) | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| Category: Immunology | ||||||
| 11/18/2017 | Covidien LP | Manometry (Device) | Travel and Lodging | In-kind items and services | $375.39 | General |
| Category: GIH | ||||||
| 11/18/2017 | Covidien LP | Manometry (Device) | Travel and Lodging | In-kind items and services | $217.22 | General |
| Category: GIH | ||||||
| 11/18/2017 | Covidien LP | Manometry (Device) | Food and Beverage | In-kind items and services | $108.69 | General |
| Category: GIH | ||||||
| 11/18/2017 | Covidien LP | Manometry (Device) | Food and Beverage | In-kind items and services | $32.35 | General |
| Category: GIH | ||||||
| 10/17/2017 | UCB, Inc. | Cimzia (Drug) | Consulting Fee | In-kind items and services | $800.00 | General |
| Category: Immunology | ||||||
| 09/14/2017 | UCB, Inc. | Cimzia (Drug) | Consulting Fee | In-kind items and services | $800.00 | General |
| Category: Immunology | ||||||
| 09/06/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $96.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/30/2017 | Intercept Pharmaceuticals, Inc. | OCA (Drug) | Food and Beverage | In-kind items and services | $185.00 | General |
| Category: Gastroenterology | ||||||
| 07/05/2017 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $123.19 | General |
| Category: Immunology | ||||||
| 05/23/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/17/2017 | Janssen Scientific Affairs, LLC | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $100.54 | General |
| Category: Immunology | ||||||
| 05/01/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Travel and Lodging | Cash or cash equivalent | $191.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/28/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/28/2017 | Covidien LP | Smart Pill (Device) | Food and Beverage | In-kind items and services | $93.23 | General |
| Category: GI Solutions | ||||||
| 04/26/2017 | Shire North American Group Inc | — | Education | In-kind items and services | $37.65 | General |
| 04/25/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $94.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Travel and Lodging | Cash or cash equivalent | $897.40 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 224 | 239 | $102,656 | $19,203 |
| 2022 | 6 | 141 | 162 | $62,303 | $13,711 |
| 2021 | 5 | 89 | 94 | $39,243 | $8,617 |
| 2020 | 4 | 76 | 78 | $36,953 | $7,964 |
Total Patients
530
Total Services
573
Medicare Billing
$49,495
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 66 | $42,214 | $8,077 | 19.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 33 | 34 | $16,868 | $2,563 | 15.2% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 35 | 38 | $8,182 | $1,864 | 22.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 13 | $13,932 | $1,616 | 11.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 23 | $4,422 | $1,388 | 31.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 14 | 15 | $4,785 | $1,268 | 26.5% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2023 | 32 | 34 | $4,876 | $1,262 | 25.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 16 | $7,377 | $1,164 | 15.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 48 | $32,097 | $6,889 | 21.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 20 | 32 | $11,145 | $2,378 | 21.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 17 | 18 | $8,550 | $1,538 | 18.0% |
| 91010 | Study of esophagus to assess movement | Facility | 2022 | 23 | 23 | $5,290 | $1,097 | 20.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 13 | 18 | $3,266 | $978.10 | 29.9% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Facility | 2022 | 23 | 23 | $1,955 | $830.96 | 42.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 33 | $22,539 | $4,860 | 21.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 14 | 15 | $7,125 | $1,370 | 19.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 12 | $4,224 | $928.67 | 22.0% |
| 91010 | Measurement of esophageal swallowing movement | Facility | 2021 | 16 | 17 | $3,910 | $830.47 | 21.2% |
| 91037 | Monitoring of gastroesophageal reflux including analysis and interpretation | Facility | 2021 | 16 | 17 | $1,445 | $627.73 | 43.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 37 | 39 | $25,251 | $5,720 | 22.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 17 | 17 | $8,397 | $1,228 | 14.6% |
| 91010 | Measurement of esophageal swallowing movement | Facility | 2020 | 11 | 11 | $2,370 | $578.35 | 24.4% |
| 91037 | Monitoring of gastroesophageal reflux including analysis and interpretation | Facility | 2020 | 11 | 11 | $935.00 | $436.97 | 46.7% |
About David Gutman, MD, FACG
David Gutman, MD, FACG is a Gastroenterology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376507079.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Gutman, MD, FACG has received a total of $13,732 in payments from pharmaceutical and medical device companies, with $164.35 received in 2023. These payments were reported across 34 transactions from 11 companies. The most common payment nature is "Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program" ($6,600).
As a Medicare-enrolled provider, Gutman has provided services to 530 Medicare beneficiaries, totaling 573 services with total Medicare billing of $49,495. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Fort Wayne, IN
- Active Since 04/12/2006
- Last Updated 08/30/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1376507079
Products in Payments
- XIFAXAN (Drug) $9,373
- Cimzia (Drug) $2,523
- Manometry (Device) $733.65
- Smart Pill (Device) $242.71
- OCA (Drug) $185.00
- VIBERZI (Drug) $150.00
- GATTEX (Drug) $119.23
- STELARA (Biological) $100.54
- RINVOQ (Biological) $59.75
- OCALIVA (Drug) $14.60
- TRULANCE (Drug) $13.10
- Alinia Tablets 500mg 30 count bottle (Drug) $2.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Wayne
Dr. Efesomwan Aisien, M.d, M.D
Gastroenterology — Payments: $89,557
Gastroenterology $89,557
Dr. Abdo Saad, Md, MD
Gastroenterology — Payments: $59,492
Gastroenterology $59,492
Melissa Garrett, Md, MD
Gastroenterology — Payments: $59,090
Gastroenterology $59,090
Dr. Mariajose Rojas De Leon, Md, MD
Gastroenterology — Payments: $39,782
Gastroenterology $39,782
Dr. Kirsten Weiser, M.d, M.D
Gastroenterology — Payments: $20,935
Gastroenterology $20,935
Sushil Jain, Md, MD
Gastroenterology — Payments: $12,708
Gastroenterology $12,708